Slack pursued an unusual direct listing, meaning it did not have banks underwrite the offering.CNBC Disruptor 50read more
President Trump says Iran may not have intentionally downed an unmanned U.S. surveillance drone.Politicsread more
Slack's CEO said that the company didn't want to go public via an IPO so that it could be as transparent and accessible as possible.Deals and IPOsread more
Oil jumped as much as 6% on Thursday after Iran shot down a U.S. military drone, prompting President Trump to blast Tehran on Twitter.Energy Commoditiesread more
If Facebook cut corners in something as basic as the branding of its nascent crypto efforts, this dispute could give ammunition to its many critics.Financeread more
CNBC analysis using Kensho found that Disney, Verizon and Home Depot were some of the best performing Dow stocks in declining-rate environments.Investingread more
For doubters thinking the rally is just a last gasp of the decade-long bull market, chart analysts are here to prove them wrong.Marketsread more
Notorious "pharma bro" Martin Shkreli has reached a settlement with his former biopharmaceutical company Retrophin just weeks ago after he sued two company directors and its...Biotech and Pharmaceuticalsread more
"The slowdown in the global economy is reaching this shore," veteran trader Art Cashin says.Economyread more
Slack's public market debut on Thursday will generate billions for venture firm Accel and healthy returns for Andreessen Horowitz and Social CapitalTechnologyread more
JetBlue is ordering the longest-range Airbus jets to expand service to more European cities.Airlinesread more
It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:
Synergy Pharmaceuticals: "I feel like if the data is good you're going to get a takeout bid. If the data is not that good I'm not sure what it's worth. We see with these things like Regulus, if they go right it's just unbelievably good. If they go bad, it's unbelievably bad. And that's why it's been so hard for me to opine on it because it seems very binary to me. And I don't like to comment on the binary. But obviously if the news is good, wow."
Charter Communications Inc: "I like Charter Communications. I happen to like the cable companies very much. This seems to be one of the best domestic businesses. You're in good shape."
Keryx Biopharmaceuticals: "We don't care where a stock has come from, we care where it is going to. This happens to be a stock I have to tell you that I think does have great speculative capabilities. I'm going to say stick with it. I don't want to buy more here because it's had a move, but I do like it because I happen to like the ones that are working on renal that are doing so well in phase three."